Vaiarelli A, Cimadomo D, Rucci C, Innocenti F, Taggi M, Pittana E
J Assist Reprod Genet. 2024; 41(12):3423-3432.
PMID: 39495342
PMC: 11707217.
DOI: 10.1007/s10815-024-03299-z.
Yusuf A, Amri M, Ugusman A, A Hamid A, Mokhtar M
Int J Mol Sci. 2024; 25(18).
PMID: 39337689
PMC: 11432676.
DOI: 10.3390/ijms251810202.
Luo X, Dong Y, Zheng H, Zhou X, Rong L, Liu X
J Ovarian Res. 2024; 17(1):79.
PMID: 38610028
PMC: 11015649.
DOI: 10.1186/s13048-024-01407-2.
Etrusco A, Mikus M, Damato A, Barra F, Planinic P, Goluza T
Biomedicines. 2024; 12(3).
PMID: 38540265
PMC: 10967775.
DOI: 10.3390/biomedicines12030653.
Kolnikaj T, Herman R, Janez A, Jensterle M
Medicina (Kaunas). 2024; 60(2).
PMID: 38399531
PMC: 10890374.
DOI: 10.3390/medicina60020244.
Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.
Yusuf A, Amri M, Ugusman A, A Hamid A, Abdul Wahab N, Mokhtar M
Int J Mol Sci. 2023; 24(15).
PMID: 37569402
PMC: 10419014.
DOI: 10.3390/ijms241512026.
The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone.
Lambalk C
F S Rep. 2023; 4(2 Suppl):27-32.
PMID: 37223768
PMC: 10201305.
DOI: 10.1016/j.xfre.2023.02.010.
Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome.
Zhang S, He H, Wang Y, Wang X, Liu X
Sci Rep. 2023; 13(1):7721.
PMID: 37173458
PMC: 10182028.
DOI: 10.1038/s41598-023-34746-z.
Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome.
Zhang J, Zhan L, Zhao M, Wang J, Xie F, Xu Z
Front Endocrinol (Lausanne). 2022; 13:971564.
PMID: 36440230
PMC: 9691951.
DOI: 10.3389/fendo.2022.971564.
Underlying mechanisms of acupuncture therapy on polycystic ovary syndrome: Evidences from animal and clinical studies.
Ye Y, Zhou C, Hu H, Fukuzawa I, Zhang H
Front Endocrinol (Lausanne). 2022; 13:1035929.
PMID: 36353235
PMC: 9637827.
DOI: 10.3389/fendo.2022.1035929.
Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.
Olaniyi K, Areloegbe S, Oyeleke M
Endocrine. 2022; 78(3):628-640.
PMID: 36114434
DOI: 10.1007/s12020-022-03191-9.
The immune system's role in PCOS.
Shamsi M, Ghazavi A, Saeedifar A, Mosayebi G, Khajeh Pour S, Ganji A
Mol Biol Rep. 2022; 49(11):10689-10702.
PMID: 35752698
DOI: 10.1007/s11033-022-07695-5.
Clinical Outcomes of Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study.
Zhang W, Liang T, Han B, Yang R, Yang S, Yang Y
Front Endocrinol (Lausanne). 2022; 13:842037.
PMID: 35311236
PMC: 8931022.
DOI: 10.3389/fendo.2022.842037.
Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.
Chappell N, Gibbons W, Blesson C
Steroids. 2022; 180:108989.
PMID: 35189133
PMC: 8920773.
DOI: 10.1016/j.steroids.2022.108989.
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.
Sadeghi H, Adeli I, Calina D, Docea A, Mousavi T, Daniali M
Int J Mol Sci. 2022; 23(2).
PMID: 35054768
PMC: 8775814.
DOI: 10.3390/ijms23020583.
Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis.
Li S, Zhang L, Wei N, Tai Z, Yu C, Xu Z
Front Endocrinol (Lausanne). 2022; 12:787854.
PMID: 34992582
PMC: 8726549.
DOI: 10.3389/fendo.2021.787854.
A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review.
Maleki V, Taheri E, Varshosaz P, Pourteymour Fard Tabrizi F, Moludi J, Jafari-Vayghan H
Reprod Biol Endocrinol. 2021; 19(1):147.
PMID: 34551795
PMC: 8459558.
DOI: 10.1186/s12958-021-00831-z.
Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome.
Chappell N, Zhou B, Hosseinzadeh P, Schutt A, Gibbons W, Blesson C
F S Sci. 2021; 2(1):101-112.
PMID: 34458875
PMC: 8392073.
DOI: 10.1016/j.xfss.2020.12.001.
Can Psychosocial Intervention Suppress Testosterone and Triglycerides Among Women With Polycystic Ovary Syndrome? A Feasibility Trial.
Yin M, Du L, Zou X, Fung Y, Sun Y, Chan C
Front Psychol. 2021; 12:690539.
PMID: 34367014
PMC: 8339270.
DOI: 10.3389/fpsyg.2021.690539.
Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls.
Chappell N, Barsky M, Shah J, Peavey M, Yang L, Sangi-Haghpeykar H
F S Rep. 2021; 1(2):125-132.
PMID: 34223228
PMC: 8244380.
DOI: 10.1016/j.xfre.2020.05.006.